Splice gene mutations, mainly involving SF3B1, SRSF2, ZRSR2, and U2AF35, are among the most common molecular alterations detected in MDS and also in patients harboring CHIP [13,14]. This evidence concerns the gene SRSF2 and myelodysplastic syndrome.